SARS-CoV-2: IDT Biologika fills vaccine candidate
In the early morning of 24 July IDT Biologika filled the second clinical batch of the newly-developed vaccine candidate…
In the early morning of 24 July IDT Biologika filled the second clinical batch of the newly-developed vaccine candidate…
HeiQ, winner of the Swiss Technology Award and Swiss Environmental Award, launches HeiQ Viroblock NPJ03, an antiviral an…